WHO considers declaring mpox outbreak a Public Health Emergency of International Concern

The WHO is poised to activate its last-resort alarm for the growing mpox outbreak in central Africa by declaring it a Public Health Emergency of International Concern (PHEIC) – with the committee responsible for the decision meeting on Wednesday.

Octapharma wins FDA approval for drug to urgently reverse effects of blood thinners

The FDA approved a new treatment option for adult patients who need an urgent reversal of blood thinners such as warfarin. Octapharma’s Balfaxar is now

July 27, 2023

Opinion | Increasing Diversity in Medicine via the Mentorship Pipeline

Jeremy Faust is editor-in-chief of , an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is author

February 22, 2024

New compound shows promise in stopping breast cancer metastasis

Researchers from the University of Liverpool have created a biomedical compound that has the potential to stop the spread of breast cancer. A recently published

July 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.